Related Experiment Video
Updated: Apr 11, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
[Progress on association between autophagy and cancer]
1Zhejiang University School of Public Health, Hangzhou 310058, China.
Abstract:
Autophagy is an evolutionarily well conserved cellular catabolic process.Cellular proteins and organelles are engulfed to autophagosomes and eventually delivered to lysosomes for degradation. Autophagy is closely associated with a variety of human diseases especially cancer. At present, it has been widely accepted that autophagy is a "double-edged sword" in cancer: it blocks tumorigenesis at the early stage, while it facilitates tumor development at the promotion and progression stage. Moreover, autophagy can be induced by chemotherapy and radiotherapy, which is generally play a pro-survival function. Thus, autophagy is an important target for cancer therapy, and suppression of autophagy to enhance the efficacy of cancer therapeutic agents is a novel strategy in cancer therapy under active clinical trials.
Insights
Autophagy, a cellular process, acts as a double-edged sword in cancer, initially blocking tumors but later aiding their growth. Suppressing autophagy is a promising cancer therapy strategy currently in clinical trials.
Area of Science:
- Cellular Biology
- Molecular Biology
- Oncology
Background:
- Autophagy is a fundamental cellular catabolic process conserved across evolution.
- It involves the degradation of cellular components via autophagosomes and lysosomes.
- Autophagy plays a complex, dual role in cancer development and progression.
Purpose of the Study:
- To explore the multifaceted role of autophagy in cancer.
- To investigate autophagy's interaction with cancer therapies like chemotherapy and radiotherapy.
- To highlight the therapeutic potential of targeting autophagy in cancer treatment.
Main Methods:
- Review of existing literature on autophagy and cancer.
- Analysis of autophagy's dual role in tumorigenesis (initiation vs. progression).
- Examination of autophagy induction by cancer treatments and its implications.
Main Results:
- Autophagy inhibits early-stage tumorigenesis but promotes later-stage tumor development.
- Chemotherapy and radiotherapy can induce autophagy, often conferring a survival advantage to cancer cells.
- Autophagy's role is context-dependent, acting as both a tumor suppressor and promoter.
Conclusions:
- Autophagy is a critical factor in cancer biology with a "double-edged sword" effect.
- Targeting and suppressing autophagy presents a novel therapeutic strategy to enhance conventional cancer treatments.
- Inhibition of autophagy is under active investigation in clinical trials for cancer therapy.
More Related Videos
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

